Table 3.
Proportion of children stunted at 6–9 years old according to intervention groups
(Risk ratio and 95 % confidence intervals)
| Proportion stunted | Unadjusted | Adjusted | |||||
|---|---|---|---|---|---|---|---|
| Intervention group | n | n | % | RR | 95 % CI* | RR | 95 % CI† |
| Three groups against the placebo | |||||||
| Placebo | 202 | 33 | 16·3 | Reference | Reference | ||
| Vitamin B12 | 201 | 28 | 13·9 | 0·85 | 0·52, 1·41 | 0·82 | 0·49, 1·35 |
| Folic acid | 204 | 37 | 18·1 | 1·11 | 0·69, 1·78 | 1·20 | 0·75, 1·92 |
| Vitamin B12 and folic acid | 184 | 23 | 12·5 | 0·76 | 0·44, 1·30 | 0·79 | 0·46, 1·35 |
| 2 × 2 groups | |||||||
| Placebo vitamin B12 | 403 | 70 | 17·2 | Reference | Reference | ||
| Vitamin B12 | 385 | 51 | 13·2 | 0·77 | 0·54, 1·10 | 0·73 | 0·51, 1·05 |
| Placebo folic acid | 406 | 60 | 15·1 | Reference | Reference | ||
| Folic acid | 388 | 60 | 15·5 | 1·02 | 0·71, 1·46 | 1·10 | 0·77, 1·58 |
Generalised linear model with the Poisson family and log link.
Adjusted for wealth quintiles.